Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XEEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XEEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCVEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.31.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.31.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.50EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.78EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.43EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HR.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HR.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.62EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.23EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JV.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.34.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.79EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.79EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GG.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used